Surgical Adhesion Barriers Pipeline Report 2023, including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

DUBLIN, Jan. 22, 2024 /PRNewswire/ -- The "Surgical Adhesion Barriers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.

The Medical Devices sector report provides comprehensive information about the Surgical Adhesion Barriers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Adhesions are bands of scar-like tissue that forms abnormal fibrous connections joining tissue surfaces in abnormal locations. In general, any type of transperitoneal operation can lead to the formation of adhesions ranging from minimal scarring of serosal surface to firm agglutination of nearly all structures.

Report Scope

• Extensive coverage of the Surgical Adhesion Barriers under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Surgical Adhesion Barriers and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

The report enables you to:

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Surgical Adhesion Barriers under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Surgical Adhesion Barriers Overview

3 Products under Development
3.1 Surgical Adhesion Barriers - Pipeline Products by Stage of Development
3.2 Surgical Adhesion Barriers - Pipeline Products by Segment
3.3 Surgical Adhesion Barriers - Pipeline Products by Territory
3.4 Surgical Adhesion Barriers - Pipeline Products by Regulatory Path
3.5 Surgical Adhesion Barriers - Pipeline Products by Estimated Approval Date
3.6 Surgical Adhesion Barriers - Ongoing Clinical Trials

4 Surgical Adhesion Barriers - Pipeline Products under Development by Companies
4.1 Surgical Adhesion Barriers Companies - Pipeline Products by Stage of Development
4.2 Surgical Adhesion Barriers - Pipeline Products by Stage of Development

5 Surgical Adhesion Barriers Companies and Product Overview

6 Surgical Adhesion Barriers- Recent Developments
6.1 Jul 21, 2023: Seikagaku Announces Favorable Results From A Pivotal Study for Si-449, an Adhesion Barrier
6.2 Jun 28, 2023: Medline Announces Leadership Transition Naming New CEO and President & COO
6.3 May 17, 2023: S2Medical AB (publ) signs a distribution agreement for the Iranian market
6.4 Apr 13, 2023: S2Medical AB (publ) signs a distributor agreement in the United Arab Emirates and delivers a record order of the skin substitute Epiprotect worth about SEK 2 million

List of Tables

• Surgical Adhesion Barriers - Pipeline Products by Stage of Development
• Surgical Adhesion Barriers - Pipeline Products by Segment
• Surgical Adhesion Barriers - Pipeline Products by Territory
• Surgical Adhesion Barriers - Pipeline Products by Regulatory Path
• Surgical Adhesion Barriers - Pipeline Products by Estimated Approval Date
• Surgical Adhesion Barriers - Ongoing Clinical Trials
• Surgical Adhesion Barriers Companies - Pipeline Products by Stage of Development
• Surgical Adhesion Barriers - Pipeline Products by Stage of Development
• Glossary

List of Figures

• Surgical Adhesion Barriers - Pipeline Products by Stage of Development
• Surgical Adhesion Barriers - Pipeline Products by Segment
• Surgical Adhesion Barriers - Pipeline Products by Territory
• Surgical Adhesion Barriers - Pipeline Products by Regulatory Path
• Surgical Adhesion Barriers - Pipeline Products by Estimated Approval Date
• Surgical Adhesion Barriers - Ongoing Clinical Trials

A selection of companies mentioned in this report includes

• Actamax Surgical Materials LLC
• Alafair Biosciences Inc
• Anika Therapeutics Inc
• ARC Medical Devices Inc
• Baxter International Inc
• BioActive Polymers in Lund AB
• Dalim Tissen Co Ltd
• Duke University
• FzioMed Inc
• Genzyme Corp
• HydroGlaze BV
• Innocoll Technologies Ltd (Inactive)
• Jinwoo Bio Co Ltd
• Kytogenics Pharmaceuticals Inc
• Leader Biomedical Europe BV
• Luna Innovations Inc
• Magen OrthoMed Ltd
• Maxigen Biotech Inc
• Medisse BV (Inactive)
• MLM Biologics Inc
• PolyNovo Biomaterials Pty Ltd
• Rutgers The State University of New Jersey
• Seikagaku Corp
• Sporogenics Pte Ltd
• Stony Brook University
• Toray Medical Co Ltd
• Tribos LLC
• TYBR Health Inc
• University of North Carolina at Chapel Hill

For more information about this report visit https://www.researchandmarkets.com/r/dg9tga

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets